Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs

Jodi L. Layton, Brian Lewis, Charles Ryan, Tomasz M. Beer, Oliver Sartor

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

It is common for patients to have limited access to oral antineoplastics or to discontinue treatment because of cost. Such oral treatments are also discontinued because of toxicity, disease progression, or death, resulting in unused portions of these medications. Policies for the subsequent use or destruction of unused drugs exist, but none completely address the need for methods of recycling back to the patients in need. This article addresses this wastefulness and ways to minimize it so that more patients benefit.

Original languageEnglish (US)
Pages (from-to)291-292
Number of pages2
JournalOncologist
Volume24
Issue number3
DOIs
StatePublished - Mar 2019

Fingerprint

Dive into the research topics of 'Recycling Discarded Drugs: Improving Access to Oral Antineoplastic Drugs'. Together they form a unique fingerprint.

Cite this